Leading Minds in Life Sciences
Delivering sustainable results on every project, every time.
Solving Complex Problems
Support from product development to post launch.
Managing Costs
When process impacts quality, product is at risk. Our seasoned consultants are experts in providing solutions to complex problems.
Gaining Regulatory Approval
A streamlined operation, compliant product and proper paperwork will get you through the FDA and onto the shelf.
Impacting Humankind
We understand the pressure that exists in Life Sciences to ensure a reliable supply of life saving medicine.

Services

QUALITY

Tunnell Consulting can help you improve and maintain a robust quality function.

REGULATORY

Tunnell helps you navigate the regulatory landscape throughout the product life cycle.

COMPLIANCE

Tunnell creates solutions that help you meet each compliance requirement.

OPERATIONAL EXCELLENCE

Tunnell partners with you to transform your business.

MANUFACTURING SCIENCE & TECHNOLOGY

We help you solve your most challenging technical problems.

INDUSTRIES

PHARMACEUTICAL

Delivering measurable results in the pharmaceutical industry.

BIOTECHNOLOGY

Supporting Biotechnology throughout the product’s life cycle.

VACCINES/BIOLOGICS

Maximizing processes and systems for long-term success.

GOVERNMENT

Serving government agencies with scientific expertise.

INSIGHTS

PRESS RELEASES & NEWSLETTERS

Tunnell Consulting Announces Bill Connell’s Appointment as Principal

EVENTS

Data Integrity East

  • March 4-5, 2019, Boston MA
Kip Wolf to speak on ‘Regulatory Guidance for Data Integrity’

PUBLISHED ARTICLES

What Your Organizational Design Says About Your Commitment To Data Integrity

Bioprocess Online
Kip Wolf discusses why quality is everyone’s responsibility.

MEDIA MENTIONS

Forbes.com: New to Business Development? 10 Hot Industries to Join Right Now

Forbes.com
Tunnell CEO, Maryann Gallivan, is quoted in Forbes.com about the appeal of the life sciences industry for new graduates

AWARDS & RECOGNITIONS

Julia O’Neill to be the latest addition to the OUTSOURCED PHARMA Team of Board Members

CASE STUDIES

Assessing Risk in Seeds & Cell Banks Practices: Avoid Costly Disruptions in Vaccine Manufacturing

Tunnell assessed each risk identified and evaluated its degree of potential impact.
Scroll to Top